Cagrilintide
5mg99% Purity
Research Use Only
Not For Human Consumption
SKU CGL5
Cagrilintide
A long-acting amylin analog investigated for satiety and complementary metabolic signaling.
- Category
- Weight Management
- Compound Type
- GLP-1 / Incretin
- Purity
- ≥ 99% HPLC
- Options
- 2 specs
Pause, skip or cancel anytime. TRU AutoShip is a delivery program, not a membership.
For laboratory and research use only. Not for human consumption.
Cagrilintide
Pause, skip or cancel anytime. TRU AutoShip is a delivery program, not a membership.
Understanding Cagrilintide
Cagrilintide belongs to the incretin mimetic class of research peptides, studied for its influence on the gut–brain axis that governs appetite, satiety, and glucose handling. Investigational literature has explored how sustained receptor engagement affects energy intake, gastric emptying, and metabolic set points. As a research reference material, Cagrilintide is characterized for purity and identity so investigators can study these signaling pathways under controlled conditions.
How it is studied to work
Receptor engagement
Binds incretin receptors (GLP-1 and, for dual/triple agonists, GIP and glucagon) expressed in the pancreas, gut, and central nervous system.
Satiety signaling
Modulates hypothalamic appetite circuits, studied for reductions in food intake and prolonged satiety.
Glucose-dependent response
Investigated for glucose-dependent insulinotropic activity, slowing gastric emptying and blunting post-prandial excursions.
Energy balance
Explored for downstream effects on energy expenditure and body composition over sustained exposure.
Where investigators are looking
Appetite & satiety
Central and peripheral regulation of hunger signaling.
Glycemic control
Glucose-dependent insulin dynamics and insulin sensitivity.
Body composition
Adiposity, lean mass retention, and metabolic set point.
Cardiometabolic markers
Lipid profiles and inflammatory signaling in metabolic models.
Catalog & pricing
- CGL55mg vial—
- CGL1010mg vial—
Keeping it stable
Lyophilized (unopened)
Stable at room temperature for short periods; store at -20°C for long-term stability.
After reconstitution
Refrigerate at 2–8°C and use within 2–4 weeks depending on the compound.
Protect from light & heat
Avoid repeated freeze–thaw cycles and prolonged light exposure.
Handling
For laboratory research use only; handle with appropriate protective equipment.
Preparing the compound
- 1
Allow both the peptide vial and bacteriostatic water to reach room temperature.
- 2
Swab both rubber stoppers with an alcohol wipe.
- 3
Draw the desired volume of bacteriostatic water into a sterile syringe.
- 4
Inject the water slowly against the inside wall of the vial — never directly onto the powder.
- 5
Swirl gently (do not shake) until the solution is fully clear.
- 6
Label with the date and store refrigerated.
Reconstitution volume determines concentration. Use a peptide calculator to match your research protocol. Bacteriostatic water is sold separately as an accessory.
Third-party verified purity
Every lot of Cagrilintide is independently tested by HPLC and mass spectrometry to confirm identity and purity. Download the current Certificate of Analysis or request the report for a specific batch.
Cagrilintide, explained
Cagrilintide is supplied strictly as a research reference material for in-vitro and laboratory study. It is characterized for purity and identity and is not intended for human consumption or therapeutic use.
Every batch is third-party tested by HPLC and mass spectrometry. A Certificate of Analysis (COA) is available for each lot from the COA section on this page.
Cagrilintide is sold by the individual vial in 2 vial sizes. See the specifications table above for catalog numbers and per-vial pricing.
This compound ships lyophilized. Reconstitute with bacteriostatic water following the steps in the Reconstitution section, then store refrigerated.
Compounds ship in protective packaging. Follow the storage guidance on this page — most lyophilized peptides are best kept at -20°C long-term and refrigerated after reconstitution.
Selected literature
- 1.
Mechanisms of action and therapeutic application of GLP-1
Drucker DJ. Cell Metabolism, 2018
- 2.
Incretin hormones: their role in health and disease
Nauck MA, Meier JJ. Diabetes, Obesity and Metabolism, 2018
- 3.
Multi-receptor agonism in metabolic research
Coskun T, et al. Molecular Metabolism, 2022
References are provided for educational and research context only and do not constitute medical claims.
Studied alongside Cagrilintide
Retatrutide
99% Purity
Research Use Only
Not For Human Consumption
Weight Management
Retatrutide
A triple-agonist incretin mimetic studied for its effects on appetite regulation, energy expenditure, and metabolic balance.
Tirzepatide
99% Purity
Research Use Only
Not For Human Consumption
Weight Management
Tirzepatide
A dual GIP/GLP-1 receptor agonist researched for satiety signaling, glucose handling, and body composition.
Semaglutide
99% Purity
Research Use Only
Not For Human Consumption
Weight Management
Semaglutide
A GLP-1 receptor agonist studied for appetite modulation and metabolic regulation.
